Ensign Group [ENSG] vs DaVita [DVA] Detailed Stock Comparison
Ensign Group
NASDAQ
Loading...
DaVita
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Ensign Group wins in 5 metrics, DaVita wins in 14 metrics, with 0 ties. DaVita appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ensign Group | DaVita | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 28.84 | 12.76 | DaVita |
| Price-to-Book Ratio | 4.56 | 6.33 | Ensign Group |
| Debt-to-Equity Ratio | 100.93 | 825.19 | Ensign Group |
| PEG Ratio | 26.16 | 11.49 | DaVita |
| EV/EBITDA | 22.09 | 8.65 | DaVita |
| Profit Margin (TTM) | 7.00% | 6.35% | Ensign Group |
| Operating Margin (TTM) | 8.46% | 15.70% | DaVita |
| EBITDA Margin (TTM) | 8.46% | 15.70% | DaVita |
| Return on Equity | 17.54% | 57.94% | DaVita |
| Return on Assets (TTM) | 5.30% | 7.15% | DaVita |
| Free Cash Flow (TTM) | $188.95M | $1.47B | DaVita |
| Dividend Yield | 0.20% | N/A | N/A |
| 1-Year Return | 13.72% | -7.70% | Ensign Group |
| Price-to-Sales Ratio (TTM) | 2.01 | 0.70 | DaVita |
| Enterprise Value | $10.83B | $23.26B | DaVita |
| EV/Revenue Ratio | 2.35 | 1.77 | DaVita |
| Gross Profit Margin (TTM) | 16.19% | 33.08% | DaVita |
| Revenue per Share (TTM) | $81 | $164 | DaVita |
| Earnings per Share (Diluted) | $5.57 | $10.15 | DaVita |
| Beta (Stock Volatility) | 1.02 | 1.09 | Ensign Group |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ensign Group vs DaVita Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ensign Group | 0.86% | 5.85% | 10.15% | 17.87% | 24.30% | 20.89% |
| DaVita | 1.42% | -6.48% | -9.94% | -9.84% | -25.37% | -13.56% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ensign Group | 13.72% | 82.87% | 189.21% | 609.18% | 3,477.51% | 3,798.79% |
| DaVita | -7.70% | 40.03% | 57.60% | 61.31% | 304.18% | 448.96% |
Performance & Financial Health Analysis: Ensign Group vs DaVita
| Metric | ENSG | DVA |
|---|---|---|
| Market Information | ||
| Market Cap | $9.27B | $9.26B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 494,640 | 1,047,040 |
| 90 Day Avg. Volume | 440,357 | 883,743 |
| Last Close | $160.63 | $129.50 |
| 52 Week Range | $118.73 - $162.05 | $126.07 - $179.60 |
| % from 52W High | -0.88% | -27.90% |
| All-Time High | $162.05 (Aug 08, 2025) | $179.60 (Jan 27, 2025) |
| % from All-Time High | -0.88% | -27.90% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.19% | 0.06% |
| Quarterly Earnings Growth | 0.19% | -0.11% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | 0.06% |
| Operating Margin (TTM) | 0.08% | 0.16% |
| Return on Equity (TTM) | 0.18% | 0.58% |
| Debt to Equity (MRQ) | 100.93 | 825.19 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $35.23 | $-4.98 |
| Cash per Share (MRQ) | $7.30 | $10.34 |
| Operating Cash Flow (TTM) | $462.89M | $1.86B |
| Levered Free Cash Flow (TTM) | $30.01M | $1.10B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.20% | N/A |
| Last 12-Month Dividend | $0.30 | N/A |
Valuation & Enterprise Metrics Analysis: Ensign Group vs DaVita
| Metric | ENSG | DVA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 28.84 | 12.76 |
| Forward P/E | 26.16 | 11.49 |
| PEG Ratio | 26.16 | 11.49 |
| Price to Sales (TTM) | 2.01 | 0.70 |
| Price to Book (MRQ) | 4.56 | 6.33 |
| Market Capitalization | ||
| Market Capitalization | $9.27B | $9.26B |
| Enterprise Value | $10.83B | $23.26B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.35 | 1.77 |
| Enterprise to EBITDA | 22.09 | 8.65 |
| Risk & Other Metrics | ||
| Beta | 1.02 | 1.09 |
| Book Value per Share (MRQ) | $35.23 | $-4.98 |
Financial Statements Comparison: Ensign Group vs DaVita
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ENSG | DVA |
|---|---|---|
| Revenue/Sales | $1.23B | $3.22B |
| Cost of Goods Sold | $1.03B | $2.24B |
| Gross Profit | $198.79M | $983.87M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $103.90M | $433.33M |
| EBITDA | $140.17M | $597.84M |
| Pre-Tax Income | $112.36M | $286.33M |
| Income Tax | $27.89M | $54.12M |
| Net Income (Profit) | $84.47M | $232.22M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ENSG | DVA |
|---|---|---|
| Cash & Equivalents | $282.67M | $438.78M |
| Total Current Assets | $986.39M | $3.64B |
| Total Current Liabilities | $705.21M | $2.91B |
| Long-Term Debt | $1.91B | $11.72B |
| Total Shareholders Equity | $1.93B | $1.66B |
| Retained Earnings | $1.50B | $1.70B |
| Property, Plant & Equipment | $2.32B | $11.65B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ENSG | DVA |
|---|---|---|
| Operating Cash Flow | $97.90M | $287.94M |
| Capital Expenditures | $-42.93M | $-143.26M |
| Free Cash Flow | $29.29M | $36.75M |
| Debt Repayment | $-1.01M | $-345.97M |
| Common Stock Repurchase | $-10.79M | $-541.85M |
Short Interest & Institutional Ownership Analysis
| Metric | ENSG | DVA |
|---|---|---|
| Shares Short | 1.87M | 5.87M |
| Short Ratio | 5.73 | 6.89 |
| Short % of Float | 0.04% | 0.15% |
| Average Daily Volume (10 Day) | 494,640 | 1,047,040 |
| Average Daily Volume (90 Day) | 440,357 | 883,743 |
| Shares Outstanding | 57.44M | 80.54M |
| Float Shares | 55.24M | 35.72M |
| % Held by Insiders | 0.03% | 0.50% |
| % Held by Institutions | 0.95% | 0.51% |
Dividend Analysis & Yield Comparison: Ensign Group vs DaVita
| Metric | ENSG | DVA |
|---|---|---|
| Last 12-Month Dividend | $0.30 | N/A |
| Last 12-Month Dividend Yield | 0.20% | N/A |
| 3-Year Avg Annual Dividend | $0.26 | N/A |
| 3-Year Avg Dividend Yield | 0.05% | N/A |
| 3-Year Total Dividends | $0.78 | N/A |
| Ex-Dividend Date | Jun 30, 2025 | N/A |